Sharing Our Strength: A Research Study for Bone Marrow/Stem Cell Transplant Survivors

Not Applicable

Completed

• Conditions: Acute Lymphocytic Leukemia; Psychological Distress; Hematological Cancers; Leukemia; Acute Leukemia; Multiple Myeloma
• Interventions: Behavioral: Writing A (Experimental informative writing); Behavioral: Writing B (Experimental noninformative writing); Behavioral: Writing C (Control informative writing); Behavioral: Writing D (Control noninformative writing)

• Registration Number: NCT00701844
• Lead Sponsor: University of North Carolina, Chapel Hill

Brief Summary

The Sharing Our Strength study is being conducted to help us understand people's experiences with hematopoietic stem cell transplantation and to test a new program designed to help people recover physically and emotionally after transplant.

Detailed Description

This is a study for survivors of hematopoietic stem cell transplantation (also known as bone marrow transplant), which is an intensive medical treatment for cancers such as leukemia, lymphoma, and multiple myeloma as well as other diseases. Because it is a physically and emotionally demanding treatment, many people report having ongoing physical and emotional difficulties after having a transplant. The Sharing Our Strength study is being conducted to help us understand people's transplant experiences and to test a new program designed to help them recover physically and emotionally after transplant. All parts of the study are completed by mail and telephone. Participants will receive compensation for their time.

Study Timeline

• Study Start: 2007-07
• Study First Submitted: 2008-06-04
• Study First Submitted QC: 2008-06-18
• Study First Posted: 2008-06-19
• Primary Completion: 2011-09
• Study Completion: 2011-09
• Status Verified: 2013-05
• Last Update Submitted: 2017-11-14
• Last Update Posted: 2017-11-17

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 315

Inclusion Criteria

• Be a transplant survivor who is 9 months to 3 years beyond transplant and not currently relapsed. and not currently relapsed
• Be at least 18 years old now (and at least 16 when they had their transplant)
• Speak English
• Have telephone service

Read More

Exclusion Criteria

• None

Read More

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: FACTORIAL

Arm && Interventions

Group	Intervention	Description
Experimental Writing Type 1	Writing A (Experimental informative writing)	-
Experimental Writing type 2	Writing B (Experimental noninformative writing)	-
Control writing type 1	Writing C (Control informative writing)	-
Control writing type 2	Writing D (Control noninformative writing)	-

Primary Outcome Measures

Name	Time	Method
Psychological Adjustment	At screening, baseline and 3 months following intervention

Secondary Outcome Measures

Name	Time	Method
Quality of Life	At screening, baseline and 3 months following intervention

Trial Locations

Locations (3)

Hackensack University Medical Center; 🇺🇸 Hackensack, New Jersey, United States

University of North Carolina at Chapel Hill; 🇺🇸 Chapel Hill, North Carolina, United States

Mount Sinai School of Medicine; 🇺🇸 New York, New York, United States